SCHEMBL30360599

SCHEMBL30360599

COc1cc(-c2cc3ncc(-c4ccc(N5CCN(C(C)C)CC5)cc4)cc3n2C)ccc1C#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 4/20 0.51
▸ TGFBR1 P36897 9/20 0.44
▸ ACVR1 Q04771 8/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ TLR9 Q9NR96 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ RET P07949 1/20 0.38
▸ CHEK1 O14757 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ BMPR1A P36894 2/20 0.38
▸ ACVRL1 P37023 2/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ RIPK2 O43353 1/20 0.38
▸ BMPR1B O00238 1/20 0.38
▸ ACVR1B P36896 1/20 0.38
▸ TNIK Q9UKE5 1/20 0.38
▸ MAP4K1 Q92918 2/20 0.38
▸ IL2 P60568 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26516706 1.00 FYN (0.51) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL26120751 0.95 FYN (0.49) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL30360604 0.95 FYN (0.49) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL30475493 0.92 FYN (0.50) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL26516537 0.89 FYN (0.53) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL26516612 0.85 MAP4K1 (0.49) FYNTGFBR1ACVR1KCNH2TLR9
SCHEMBL26516919 0.80 FYN (0.43) FYNTGFBR1ACVR1KCNH2MAP4K1
SCHEMBL26516610 0.79 TLR8 (0.55) FYNTGFBR1ACVR1TLR9TLR8
SCHEMBL26516625 0.77 TGFBR1 (0.63) FYNTGFBR1ACVR1TLR9TLR8
SCHEMBL30360601 0.76 MAP4K1 (0.47) FYNACVR1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN claimed
EP-4200015-A1 SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2023-06-28 — — EP disclosed
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN disclosed
Send feedback